Premium
Citalopram‐induced Photopigmentation
Author(s) -
I˚nalöz H. Serhat,
Kirtak Necmettin,
Herken Hasan,
Özgöztaşi Orhan,
Aynacioğlu A. Şükrü
Publication year - 2001
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/j.1346-8138.2001.tb00070.x
Subject(s) - citalopram , adverse effect , depression (economics) , medicine , psychiatry , serotonin reuptake inhibitor , serotonin , psychology , receptor , economics , macroeconomics
Citalopram is one of the newer and most potent selective serotonin re‐uptake inhibitor (SSRI) drugs. It has a well‐established antidepressive action with a favorable adverse event profile. We present a fifty‐year‐old woman with diffuse photopigmentation who had been diagnosed as suffering from depression. The patient was given citalopram (40 mg/day) for her psychiatric condition and diffuse photopigmentation was noted thereafter. To our knowledge, such an adverse event has not been reported previously.